Drug Type Small molecule drug |
Synonyms JRF104 |
Target |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Esophageal Carcinoma | Phase 1 | CN | 26 Apr 2023 | |
Breast Cancer | Phase 1 | CN | 02 Aug 2022 | |
Colorectal Cancer | Phase 1 | CN | 02 Aug 2022 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 16 Aug 2021 |